Construction of multi-program responsive vitamin E succinate-chitosan-histidine nanocarrier and its response strategy in tumor therapy.

[1]  Cuiyun Yu,et al.  Dual gatekeepers-modified mesoporous organic silica nanoparticles for synergistic photothermal-chemotherapy of breast cancer. , 2023, Journal of colloid and interface science.

[2]  Chenfeng Xu,et al.  Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Mateusz Kciuk,et al.  Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity , 2023, Cells.

[4]  Xinglu Jiang,et al.  Programmed-stimuli responsive carrier-free multidrug delivery system for highly efficient trimodal combination therapy. , 2023, Journal of colloid and interface science.

[5]  B. Tzang,et al.  Onion-like doxorubicin-carrying polymeric nanomicelles with tumor acidity-sensitive dePEGylation to expose positively-charged chitosan shell for enhanced cancer chemotherapy. , 2022, International Journal of Biological Macromolecules.

[6]  B. Ghaemi,et al.  Tumor acidic environment directs nanoparticle impacts on cancer cells. , 2022, Journal of colloid and interface science.

[7]  Hongyan Zhu,et al.  Synergistic Disruption of Metabolic Homeostasis through Hyperbranched Poly(ethylene glycol) Conjugates as Nanotherapeutics to Constrain Cancer Growth , 2022, Advanced materials.

[8]  R. Guo,et al.  Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. , 2021, Carbohydrate polymers.

[9]  Shuo Liu,et al.  O-carboxymethyl chitosan based pH/hypoxia-responsive micelles relieve hypoxia and induce ROS in tumor microenvironment. , 2021, Carbohydrate polymers.

[10]  Xu Cheng,et al.  Acid-sensitive and L61-crosslinked hyaluronic acid nanogels for overcoming tumor drug-resistance. , 2021, International journal of biological macromolecules.

[11]  Yan Peng,et al.  Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Ronnie H. Fang,et al.  Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs , 2021, Science Advances.

[13]  M. Rondoni,et al.  Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells , 2021, Cell Biology and Toxicology.

[14]  Yu Wang,et al.  Recent progress in nanomedicine for enhanced cancer chemotherapy , 2021, Theranostics.

[15]  Qingsong Liu,et al.  Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy. , 2021, International journal of pharmaceutics.

[16]  Lian-Hua Fu,et al.  Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy , 2021, Advanced materials.

[17]  B. Bagheri,et al.  Self-assembled heptamethine cyanine dye dimer as a novel theranostic drug delivery carrier for effective image-guided chemo-photothermal cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Y. Assaraf,et al.  Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp) , 2020, Medicinal research reviews.

[19]  Stephen J. Florczyk,et al.  3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells. , 2020, Biomaterials.

[20]  P. Xie,et al.  Core-shell-corona chitosan-based micelles for tumor intracellular pH-triggered drug delivery: Improving performance by grafting polycation. , 2019, International journal of biological macromolecules.

[21]  C. Adamo,et al.  In Silico Investigation of the Aggregation‐Caused Quenching: the “Tolane‐Based Molecule” Case , 2019, ChemPhotoChem.

[22]  R. Shiji,et al.  Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles. , 2019, International journal of biological macromolecules.

[23]  Xinyuan Zhu,et al.  A new insight into the reversal of multidrug resistance in cancer by nanodrugs. , 2019, Biomaterials science.

[24]  Xiaohua Tian,et al.  Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier. , 2019, ACS applied materials & interfaces.

[25]  Yang Wu,et al.  Efficient fabrication of reversible pH-induced carboxymethyl chitosan nanoparticles for antitumor drug delivery under weakly acidic microenvironment. , 2019, International journal of biological macromolecules.

[26]  Yangling Guo,et al.  Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel. , 2019, Carbohydrate polymers.

[27]  Gabriela G Pereira,et al.  Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery , 2019, Pharmaceutics.

[28]  P. Liu,et al.  One-pot fabrication of pH/reduction dual-stimuli responsive chitosan-based supramolecular nanogels for leakage-free tumor-specific DOX delivery with enhanced anti-cancer efficacy. , 2018, Carbohydrate polymers.

[29]  Zhenhai Zhang,et al.  Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma. , 2018, Carbohydrate polymers.

[30]  Yu Qin,et al.  Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy. , 2018, Acta biomaterialia.

[31]  Cui Tang,et al.  Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer. , 2018, Acta biomaterialia.

[32]  Jianqing Gao,et al.  Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer , 2018, Acta Pharmacologica Sinica.

[33]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[34]  Yunbing Wang,et al.  pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy. , 2018, Acta biomaterialia.

[35]  A. De Angelis,et al.  Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib , 2018, Oxidative medicine and cellular longevity.

[36]  M. Kurisawa,et al.  Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)–Green Tea Catechin Conjugate for Cancer Therapy , 2018, Advanced materials.

[37]  Conglian Yang,et al.  Recent Advances in the Application of Vitamin E TPGS for Drug Delivery , 2018, Theranostics.

[38]  Jufang Wang,et al.  pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. , 2017, Acta biomaterialia.

[39]  Hyun-Jong Cho,et al.  Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. , 2017, Acta biomaterialia.

[40]  Ruslan G. Tuguntaev,et al.  P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance. , 2017, ACS applied materials & interfaces.

[41]  O. Aharonson,et al.  A multiple-impact origin for the Moon , 2017, 1903.02525.

[42]  Ben Zhong Tang,et al.  Long-Term Real-Time In Vivo Drug Release Monitoring with AIE Thermogelling Polymer. , 2017, Small.

[43]  K. Ulbrich,et al.  Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Y. Assaraf,et al.  Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[45]  Sarah E. Seton-Rogers.  Resistance: Following different paths , 2016, Nature Reviews. Cancer.

[46]  Yadong Li.  Realize molecular surgical knife in tumor therapy by nanotechnology , 2015, Science China Materials.

[47]  Kuan-Yi Lee,et al.  Vitamin E containing polymer micelles for reducing normal cell cytotoxicity and enhancing chemotherapy efficacy. , 2015, Acta biomaterialia.

[48]  P. Chu,et al.  Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR. , 2014, Biomaterials.

[49]  M. Bentires-Alj,et al.  Mechanism-based cancer therapy: resistance to therapy, therapy for resistance , 2014, Oncogene.

[50]  Chaoliang He,et al.  Intercellular pH-responsive histidine modified dextran-g-cholesterol micelle for anticancer drug delivery. , 2014, Colloids and surfaces. B, Biointerfaces.

[51]  Jin-Zhi Du,et al.  Doxorubicin Conjugate of Poly(Ethylene Glycol)‐Block‐Polyphosphoester for Cancer Therapy , 2014, Advanced healthcare materials.

[52]  J. Ljubimova,et al.  Nanomedicine therapeutic approaches to overcome cancer drug resistance. , 2013, Advanced drug delivery reviews.

[53]  B. Rigas,et al.  Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. , 2012, Nanomedicine.

[54]  Qin Chen,et al.  Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. , 2012, Biomaterials.

[55]  Yan Zhao,et al.  Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux. , 2011, Cancer letters.

[56]  F. Sharom,et al.  ABC efflux pump-based resistance to chemotherapy drugs. , 2009, Chemical reviews.

[57]  You Han Bae,et al.  Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.

[58]  H. Kawakami,et al.  Design of a poly(L‐histidine)‐carbohydrate conjugate for a new pH‐sensitive drug carrier , 2004 .

[59]  Chava Kimchi-Sarfaty,et al.  P-glycoprotein: from genomics to mechanism , 2003, Oncogene.

[60]  G. Embery,et al.  Inhibition of hydroxyapatite crystal growth by bone proteoglycans and proteoglycan components. , 2002, Biochemical and biophysical research communications.

[61]  U. Brinkmann,et al.  ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. , 2001, Pharmacogenomics.

[62]  Zhe-Sheng Chen,et al.  The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[63]  B. Chabner,et al.  Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.

[64]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.